Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chamberlain

Showing results (171-180 of 396) with videos related to

Pageof 40
Sort By:
International Nursing Review|November 1, 1987
Primary health care in Canada: in praise of the nurse?M C Chamberlain, A C Beckingham
Cancer|March 17, 2004
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiformeMarc C Chamberlain, Denice D Tsao-Wei
Annals of Neurology|July 1, 1993
Quantitative cerebrospinal fluid cytology in patients receiving intracavitary chemotherapyV Russack, S Kim, M C Chamberlain
Annals of Clinical Biochemistry|June 23, 1998
Dietary treatment of hypercholesterolaemia: lack of relationship between individual response and genetic variation at the lipase loci. The Fluvastatin Genotyping GroupJ C Chamberlain, D Hill, A Shenkin
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Adult intradural primary spinal cord tumorsKamran Aghayev, Frank Vrionis, Marc C Chamberlain
Expert Review of Neurotherapeutics|September 30, 2011
Medical treatment of recurrent meningiomasMarc C Chamberlain, Jill S Barnholtz-Sloan
Oncology Reports|April 18, 1998
Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitisM C Chamberlain, P Kormanik, M Glantz
Cancer Control : Journal of the Moffitt Cancer Center|May 31, 2017
Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain TumorsSajeel Chowdhary, Sherri Damlo, Marc C Chamberlain
Current Neurology and Neuroscience Reports|February 22, 2012
Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumorsJames Fink, Donald Born, Marc C Chamberlain
Current Treatment Options in Oncology|May 20, 2011
Pseudoprogression: relevance with respect to treatment of high-grade gliomasJames Fink, Donald Born, Marc C Chamberlain
Pageof 40

Showing results (171-180 of 396) with videos related to

Sort By:
Pageof 40
International Nursing Review|November 1, 1987
Primary health care in Canada: in praise of the nurse?M C Chamberlain, A C Beckingham
Cancer|March 17, 2004
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiformeMarc C Chamberlain, Denice D Tsao-Wei
Annals of Neurology|July 1, 1993
Quantitative cerebrospinal fluid cytology in patients receiving intracavitary chemotherapyV Russack, S Kim, M C Chamberlain
Annals of Clinical Biochemistry|June 23, 1998
Dietary treatment of hypercholesterolaemia: lack of relationship between individual response and genetic variation at the lipase loci. The Fluvastatin Genotyping GroupJ C Chamberlain, D Hill, A Shenkin
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Adult intradural primary spinal cord tumorsKamran Aghayev, Frank Vrionis, Marc C Chamberlain
Expert Review of Neurotherapeutics|September 30, 2011
Medical treatment of recurrent meningiomasMarc C Chamberlain, Jill S Barnholtz-Sloan
Oncology Reports|April 18, 1998
Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitisM C Chamberlain, P Kormanik, M Glantz
Cancer Control : Journal of the Moffitt Cancer Center|May 31, 2017
Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain TumorsSajeel Chowdhary, Sherri Damlo, Marc C Chamberlain
Current Neurology and Neuroscience Reports|February 22, 2012
Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumorsJames Fink, Donald Born, Marc C Chamberlain
Current Treatment Options in Oncology|May 20, 2011
Pseudoprogression: relevance with respect to treatment of high-grade gliomasJames Fink, Donald Born, Marc C Chamberlain
Pageof 40